{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:41:13Z","timestamp":1761709273649,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.revmed.2016.10.389","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T11:31:51Z","timestamp":1479900711000},"page":"482-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Histiocytose langerhansienne et maladie d\u2019Erdheim-Chester, une continuit\u00e9\u00a0?"],"prefix":"10.1016","volume":"38","author":[{"given":"S.","family":"Parreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Haroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pommepuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Emile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Bourras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Archambeaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2016.10.389_bib0165","article-title":"Classification histologique et alt\u00e9rations mol\u00e9culaires des histiocytoses","author":"Emile","year":"2016","journal-title":"Presse Med"},{"issue":"11","key":"10.1016\/j.revmed.2016.10.389_bib0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.revmed.2014.04.007","article-title":"Erdheim-Chester disease","volume":"35","author":"Haroche","year":"2014","journal-title":"Rev Med Interne"},{"issue":"7","key":"10.1016\/j.revmed.2016.10.389_bib0175","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.mayocp.2014.01.023","article-title":"Erdheim-Chester disease: characteristics and management","volume":"89","author":"Munoz","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.revmed.2016.10.389_bib0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.semarthrit.2011.11.004","article-title":"Treatment of Erdheim-Chester disease with long-term high-dose interferon-\u03b1","volume":"41","author":"Hervier","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2016.10.389_bib0185","article-title":"La maladie d\u2019Erdheim-Chester, une n\u00e9oplasie my\u00e9lo\u00efde inflammatoire","author":"Haroche","year":"2016","journal-title":"Presse Med"},{"issue":"10","key":"10.1016\/j.revmed.2016.10.389_bib0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.revmed.2015.04.015","article-title":"Langerhans cell histiocytosis in adults","volume":"36","author":"Neel","year":"2015","journal-title":"Rev Med Interne"},{"issue":"1","key":"10.1016\/j.revmed.2016.10.389_bib0195","first-page":"84","article-title":"Histiocytosis X integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Sch\u00fcller-Christian disease as related manifestations of a single nosologic entity","volume":"56","author":"Lichtenstein","year":"1953","journal-title":"AMA Arch Pathol"},{"issue":"7","key":"10.1016\/j.revmed.2016.10.389_bib0200","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","article-title":"Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation","volume":"124","author":"Hervier","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.revmed.2016.10.389_bib0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrendo.2010.198","article-title":"A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening","volume":"7","author":"Tritos","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"11","key":"10.1016\/j.revmed.2016.10.389_bib0210","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/jcp.2004.018481","article-title":"Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature","volume":"57","author":"Sheu","year":"2004","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.revmed.2016.10.389_bib0215","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53\u00a0patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.revmed.2016.10.389_bib0220","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.annder.2011.06.002","article-title":"Associated Langerhans cell histiocytosis and Erdheim-Chester disease","volume":"138","author":"Marchal","year":"2011","journal-title":"Ann Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.revmed.2016.10.389_bib0225","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tem.2007.06.003","article-title":"Endocrine manifestations in Langerhans cell histiocytosis","volume":"18","author":"Makras","year":"2007","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.revmed.2016.10.389_bib0230","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2009.08.013","article-title":"Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis","volume":"63","author":"Tsai","year":"2010","journal-title":"J Am Acad Dermatol"},{"year":"2008","series-title":"World Health Organization classification of tumors of hematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.revmed.2016.10.389_bib0235"},{"issue":"3","key":"10.1016\/j.revmed.2016.10.389_bib0240","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199407213310303","article-title":"Langerhans\u2019-cell histiocytosis (histiocytosis X)\u00a0\u2013\u00a0a clonal proliferative disease","volume":"331","author":"Willman","year":"1994","journal-title":"N Engl J Med"},{"issue":"8900","key":"10.1016\/j.revmed.2016.10.389_bib0245","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(94)91842-2","article-title":"Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis","volume":"343","author":"Yu","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.revmed.2016.10.389_bib0250","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.pas.0000213366.33627.a0","article-title":"Clonal cytogenetic abnormalities in Erdheim-Chester disease","volume":"31","author":"Vencio","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.revmed.2016.10.389_bib0255","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2012.46.9676","article-title":"BRAF mutations in Erdheim-Chester disease","volume":"31","author":"Emile","year":"2013","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.revmed.2016.10.389_bib0260","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2012-05-430140","article-title":"High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses","volume":"120","author":"Haroche","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.revmed.2016.10.389_bib0265","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1\u00a0mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.revmed.2016.10.389_bib0270","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2014-04-570937","article-title":"Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease","volume":"124","author":"Emile","year":"2014","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.revmed.2016.10.389_bib0275","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2013-06-511139","article-title":"Somatic activating ARAF mutations in Langerhans cell histiocytosis","volume":"123","author":"Nelson","year":"2014","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.revmed.2016.10.389_bib0280","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1182\/blood-2015-01-625491","article-title":"Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis","volume":"125","author":"H\u00e9ritier","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2016.10.389_bib0285","first-page":"949163","article-title":"A rare case of Erdheim-Chester disease and langerhans cell histiocytosis overlap syndrome","volume":"2015","author":"Nabi","year":"2015","journal-title":"Case Rep Pathol"},{"issue":"9","key":"10.1016\/j.revmed.2016.10.389_bib0290","first-page":"601","article-title":"Erdheim-Chester disease: report of a case, review of the literature and discussion of the relation to Langerhans-cell histiocytosis","volume":"60","author":"Pertuiset","year":"1993","journal-title":"Rev Rhum"},{"issue":"3","key":"10.1016\/j.revmed.2016.10.389_bib0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00005792-199605000-00005","article-title":"Erdheim-Chester disease. Clinical and radiologic characteristics of 59\u00a0cases","volume":"75","author":"Veyssier-Belot","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.revmed.2016.10.389_bib0300","first-page":"335","article-title":"[Langerhans-cell histiocytosis and Erdheim-Chester disease: probably not a fortuitous association]","volume":"125","author":"Boralevi","year":"1998","journal-title":"Ann Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.revmed.2016.10.389_bib0305","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/1744666X.2015.1060857","article-title":"The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm","volume":"11","author":"Haroche","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.revmed.2016.10.389_bib0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bjh.13247","article-title":"Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to histiocytosis X?","volume":"169","author":"Berres","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.revmed.2016.10.389_bib0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"JCO"},{"issue":"20","key":"10.1016\/j.revmed.2016.10.389_bib0160","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood-2010-04-279240","article-title":"Rationale and efficacy of interleukin-1\u00a0targeting in Erdheim-Chester disease","volume":"116","author":"Aouba","year":"2010","journal-title":"Blood"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866316309705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:38:15Z","timestamp":1759336695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866316309705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0248866316309705"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.389","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histiocytose langerhansienne et maladie d\u2019Erdheim-Chester, une continuit\u00e9\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2016.10.389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}